Purpose: Used for targeted therapy in the treatment of various cancers, including kidney cancer and gastrointestinal stromal tumors (GIST).
Active Ingredient: Sunitinib Maleate.
Dosage Strength: Each capsule contains 25 mg of sunitinib maleate.
Dosage Form: Oral capsule.
Mechanism of Action: Inhibits multiple receptor tyrosine kinases involved in cancer cell proliferation and angiogenesis.
Indications: Effective against renal cell carcinoma and GIST.
Contraindications: Hypersensitivity to sunitinib or its components.
Adverse Reactions: Common side effects include fatigue, diarrhea, nausea, and hypertension; may also cause hand-foot syndrome and hematologic toxicities.
Storage: Store at room temperature, protect from light and moisture.
Prescription: Typically prescribed by oncologists or healthcare professionals experienced in cancer treatment.
Counseling: Educate patients on proper dosing, potential side effects, and the importance of regular monitoring.
Pregnancy/Lactation: Avoid during pregnancy and breastfeeding; discuss risks with healthcare provider.
Interactions: Check for potential interactions with other medications, especially those metabolized by CYP3A4.